St. Jude Gearing For SCD-HeFT Implants, Anticipates Medicare Rewards
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Medical will start to reap the benefits of Medicare's coverage policy for implantable cardioverter defibrillators now that CMS has established an ICD registry, the company predicted April 21 during its first-quarter earnings call
You may also be interested in...
Heart Rhythm Society Members Offer CMS Advice On ICD Registry Creation
The National ICD Registry Working Group will collaborate with CMS to establish better definitions for how physicians should record information on the implantable cardioverter defibrillator registry data collection form
Medtronic Foresees Gradual ICD Uptake, Reviews Battery Problem
Demand for Medtronic's implantable cardioverter defibrillators in response to CMS' January coverage decision will increase gradually over the next several quarters rather than in one dramatic surge, according to the company
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.